B&L Focuses On Brand Recognition For Zyoptix DTC Campaign

Detailed information on risks associated with Bausch & Lomb's Zyoptix wavefront ablation system will be available in print and web forms as a supplement to TV broadcast advertising for the product

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight